Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 76 (7) , 480-484
- https://doi.org/10.1016/s0002-9149(99)80134-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Low-Density Lipoprotein Density and AtherosclerosisPublished by American Medical Association (AMA) ,1994
- Comparative Effects of Lovastatin and Niacin in Primary HypercholesterolemiaArchives of internal medicine (1960), 1994
- Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaThe American Journal of Cardiology, 1994
- Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.Circulation, 1993
- Long-term predictors of subsequent cardiovascular events with coronary artery disease and 'desirable' levels of plasma total cholesterol.Circulation, 1992
- Marked benefit with sustained-release niacin therapy in patients with “isolated” very low levels of high-density lipoprotein cholesterol and coronary artery diseaseThe American Journal of Cardiology, 1992
- Low density lipoprotein particle size and coronary artery disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with “desirable” total cholesterol levelsThe American Journal of Cardiology, 1991
- Influence of Magnesium Substitution Therapy on Blood Lipid Composition in Patients With Ischemic Heart DiseaseArchives of internal medicine (1960), 1989
- Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM SubjectsDiabetes Care, 1989